Genematrix Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
6,868
4,666
9,984
9,529
7,652
Total Accounts Receivable
3,146
2,918
2,538
2,082
2,262
Inventories
1,468
1,634
1,097
838
942
Other Current Assets
251
221
335
243
427
Total Current Assets
11,733
9,439
13,954
12,692
11,283
Net Property, Plant & Equipment
7,259
7,019
6,733
6,662
6,552
Total Investments and Advances
7
44
24
-
-
Intangible Assets
636
563
216
111
85
Other Assets
57
-
-
26
26
Total Assets
19,822
17,228
24,003
22,878
21,692
ST Debt & Current Portion LT Debt
4,205
3,700
4,100
4,100
4,100
Accounts Payable
447
317
253
205
197
Income Tax Payable
31
15
12
19
15
Other Current Liabilities
1,657
616
765
850
728
Total Current Liabilities
6,340
4,648
5,131
5,174
5,040
Long-Term Debt
-
-
4,644
-
-
Provision for Risks & Charges
509
521
513
510
624
Deferred Taxes
8
8
141
145
195
Other Liabilities
56
-
462
59
140
Total Liabilities
7,043
5,340
13,966
9,276
9,747
Common Equity (Total)
11,255
10,226
8,676
12,483
11,059
Total Shareholders' Equity
11,255
10,226
8,676
12,483
11,059
Total Equity
12,780
11,888
10,037
13,602
11,945
Liabilities & Shareholders' Equity
19,822
17,228
24,003
22,878
21,692
Accumulated Minority Interest
1,525
1,662
1,361
1,119
886

About Genematrix

View Profile
Address
7 to 8th Floor, Korea Bio Park Bldg
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.genematrix.net
Updated 09/14/2018
GENEMATRIX, Inc. engages in the development of platform and molecular diagnostics products. Its products include pharmaceutical products for hepatology, sexually transmited diseaseds, genetic diseases, and others. The company was founded in December 7, 2000 and is headquartered in Seongnam, South Korea.